Skip to main content
PGEN
NASDAQ Life Sciences

FDA Grants Platform Technology Designation to Precigen's AdenoVerse

Tom Rudovsky · Reported by PR Newswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$7.93
Mkt Cap
$2.786B
52W Low
$2.99
52W High
$8.039
52W Position info
165% above low
Off High info
1.3% below high
Rel. Volume info
1.9× avg
Market data snapshot near publication time

PGEN has more than doubled off its 52-week low of $2.99 on elevated volume (1.9× avg).

Summary

Precigen received FDA Platform Technology Designation for its AdenoVerse platform, a regulatory milestone that can streamline future product approvals built on the technology. This follows the company's first profitable quarter in Q2 2026, driven by $53.1 million in Papzimeos sales. The designation validates the platform's broad applicability and may accelerate development timelines for multiple candidates. Investors will watch for updates on which AdenoVerse-based therapies advance next.

At the time of this announcement, PGEN was trading at $7.93 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.8B. The 52-week trading range was $2.99 to $8.04. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: PR Newswire.


Price Chart

Share this article

Copied!

PGEN - Latest Insights

PGEN
Nov 04, 2026, 4:17 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $4.99
Real-time Price: $4.40 info
Change: -$0.5873 (-12%) info
Market Cap: $1.576B info
PGEN
Nov 04, 2026, 4:05 PM EST
Source: PR Newswire
Importance Score:
8
Price at Filing: $5.01
Real-time Price: $4.40 info
Change: -$0.6113 (-12%) info
Market Cap: $1.576B info
PGEN
Aug 04, 2026, 4:08 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $7.27
Real-time Price: $4.40 info
Change: -$2.87 (-39%) info
Market Cap: $1.576B info
PGEN
Aug 04, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $7.35
Real-time Price: $4.40 info
Change: -$2.95 (-40%) info
Market Cap: $1.576B info
PGEN
Aug 04, 2026, 4:01 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $7.25
Real-time Price: $4.40 info
Change: -$2.85 (-39%) info
Market Cap: $1.576B info